Dose escalation study of proton beam therapy with concurrent chemotherapy for stage III non‐small cell lung cancer

The purpose of this study is to determine the recommended dose (RD) of proton beam therapy (PBT) for inoperable stage III non‐small cell lung cancer (NSCLC). We tested two prescribed doses of PBT: 66 Gy (relative biological effectiveness [RBE]) in 33 fractions and 74 Gy (RBE) in 37 fractions in arms...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Harada, Hideyuki, Fuji, Hiroshi, Ono, Akira, Kenmotsu, Hirotsugu, Naito, Tateaki, Yamashita, Haruo, Asakura, Hirofumi, Nishimura, Tetsuo, Takahashi, Toshiaki, Murayama, Shigeyuki
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4946725/
https://ncbi.nlm.nih.gov/pubmed/27110950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12955
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados